Why the study?
Does the implantation of heparin-coated Palmaz-Schatz stents prevent stent thrombosis and improve event-free survival in stable patients with one significant de novo coronary lesion?
Does the implantation of heparin-coated Palmaz-Schatz stents prevent stent thrombosis and improve event-free survival in stable patients with one significant de novo coronary lesion?
Heparin-coated stents appear safe and effective in preventing acute thrombosis in stable patients with single de novo coronary lesions.
Answers are grounded in this paper and cite their sources.
Supports safety of heparin-coated stents in stable single-lesion patients; leaves open randomized confirmation of benefit over uncoated stents.
The implantation of stents coated with polyamine and end-point-attached heparin in stable patients with one significant de novo coronary lesion is well tolerated, is associated with no (sub)acute stent thrombosis, and results in a favorable event-free survival after 6 months.
No takes yet. Share an insight, caveat, or question.
Serruys et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: